Climber suffers head injury in fall at quarry
Buxton Mountain Rescue Team was called to Hoffman Quarry at Harper Hill, Buxton, after a man fell while climbing at the site at around 11:22 BST on Friday.
The climber fell about 3m (9.8ft) and briefly lost consciousness due to a head injury, a spokesperson said.
He was airlifted to a location where an ambulance was waiting to take him to hospital.
Follow BBC Derby on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@bbc.co.uk or via WhatsApp on 0808 100 2210.
Peak rescue for walker with 'very nasty' injury
'Awkward' rescue for injured Peak District walker
Father-and-son Peak District outing ends in injury
Buxton Mountain Rescue
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
2 hours ago
- Forbes
Rewriting Genetic Fate: Universal Newborn Genomic Screening Arrives
Tiny baby in grey clothes sleeps on woolen blanket In Destiny's Child No Longer: Rewriting Genetic Fate, we envisioned a world where every newborn would be screened for genetic risks. We see a future in which the randomness of genetic inheritance could be met with knowledge, preparation, and, ultimately, intervention. Today, that vision is rapidly becoming reality on both sides of the Atlantic. The United Kingdom's National Health Service (NHS) has announced a landmark plan to offer whole genome sequencing to every newborn. At the same time, Florida's Sunshine Genetics Act has set the stage for a statewide pilot of newborn genomic screening. These developments are a shift in public health. They stand to transform the diagnosis, prevention, and treatment of rare diseases for generations to UK's Ambitious National Rollout The NHS's new initiative will, over the next decade, provide every newborn in England with comprehensive DNA analysis. This effort builds on the success of the Generation Study. This program sequenced the genomes of 100,000 infants to screen for over 200 rare, treatable genetic conditions. The government has committed £650 million to this program, aiming to move beyond the current heel-prick blood test—which screens for just nine conditions—to a system capable of detecting hundreds of single-gene disorders and risk factors for complex diseases. The program is shifting the NHS from reactive care to proactive, personalized healthcare. By identifying disease risks at birth, the NHS hopes to reduce the burden of illness and extending healthy lifespans. The UK's ambitious newborn genome sequencing program is set to make every newborn in England eligible for whole genome sequencing by 2030. This comprehensive framework positions the UK as a global leader in genomic medicine. Furthmore it is setting a precedent for how large-scale, ethically responsible genetic screening can be integrated into national healthcare systems for the benefit of future Sunshine Genetics Act: A U.S. Model Emerges Across the Atlantic, Florida has surged to the forefront of rare disease research with the passage of the Sunshine Genetics Act. Signed into law in July 2025, this legislation launches a five-year pilot program to sequence the genomes of newborns statewide. The Act allocates $3 million to the Sunshine Genetics Pilot Program. It establishes the Florida Institute for Pediatric Rare Diseases at Florida State University, with additional funding from both state and university sources. The program also focuses on ensuring participation remains voluntary and contingent upon parental consent. The Sunshine Genetics Consortium, formed under the Act, unites leading researchers, clinicians, and biotech innovators from across Florida's top institutions. Their mission: to accelerate diagnosis, pioneer new treatments, and end the diagnostic odyssey faced by families affected by one of the more than 7,000 rare diseases impacting 30 million and Future Directions The initiative by the UK and Florida represents a true shift, one that we predicted, in how we approach disease. Early results from multiple studies have shown that genome sequencing can identify actionable conditions and diseases. Furthermore, genome sequencing can identify these conditions far sooner than traditional screening methods. This enables interventions that can alter the course of a child's life. That said, the path to this new approach is not without challenges. As always, there are ethical concerns to address, including consent, privacy, and the potential for genetic discrimination. All these concerns require oversight, thought, and care. Additionally, equitable access to these technologies is another concern, which is important globally and will remain a pressing issue as new technologies emerge. Ongoing research and public dialogue will be essential to ensure that the benefits of genomic medicine are realized for the Science Consider the story of a family whose newborn was diagnosed with a rare metabolic disorder through genomic screening, years before symptoms would have appeared. Early intervention allowed for dietary modifications that prevented irreversible neurological damage. Stories like these are increasingly common as these programs expand. They underscore the human impact of scientific progress. As predicted in Destiny's Child No Longer, the era of universal newborn genomic screening is dawning. The UK and Florida are leading the way. They demonstrate both the promise and the responsibility that comes with rewriting genetic fate. Their experiences will inform global efforts. They will shape a future where every child's genetic destiny is not only known but can be changed for the better.
Washington Post
3 hours ago
- Washington Post
There's no vaccine for this
The simplified, somewhat apocryphal story I was taught about the origins of vaccines is this one: In 1796, at the height of the smallpox epidemic, physician Edward Jenner noticed that milkmaids who had contracted cowpox, a related but milder illness, appeared to be immune to the more severe disease, which killed 30 percent of the people who caught it. Jenner took a cowpox sample from an infected milkmaid and injected it into the arm of a willing subject, and the subject became immune, and smallpox became eradicated, and we never looked back.
Yahoo
5 hours ago
- Yahoo
UK launches fund to support people with health conditions return to work
The UK Government has launched the WorkWell Primary Care Innovation Fund, a pilot programme designed to assist individuals with health conditions return to work while simultaneously easing the workload on general practitioners (GPs). With £1.5m ($2.01m) in financial support, the initiative is set to benefit 15 regions. This approach tackles an issue where, out of the 11 million electronic fit notes issued in primary care across England last year, 93% indicated that individuals were 'not fit for work', without providing any alternative support. Funded by the Department of Health and Social Care (DHSC) and the Department for Work and Pensions (DWP), WorkWell sites will bridge this gap by connecting patients to local services that offer work and health advice. The investment will enable the hiring of professionals within GP practices. Additionally, the programme will focus on enhancing the skills of occupational therapists and physiotherapists. UK Health and Social Care Secretary Wes Streeting said: 'Every person we help back into work isn't just transforming their own life - they're contributing to our communities, our economy and breaking the cycle that's been holding Britain back.' The initiative is exploring alternative methods to reduce the administrative burden on GPs. With 90% of fit notes being issued by doctors, the new funding will investigate how other healthcare professionals can contribute to a more supportive system for both patients and employers. The WorkWell Primary Care Innovation Fund aligns with the government's ten-year Health Plan. The government has also made strides in increasing the number of GPs, with recruitment initiatives. As part of a broader effort to reduce waiting lists and improve healthcare accessibility, the government has deployed specialist clinical teams and opened new community diagnostic centres operating seven days a week. This initiative complements a £100m investment in Connect to Work programmes. Evidence from the WorkWell pilot will inform a wider strategy on work, health, and skills, as part of the government's Plan for Change. Each of the 15 WorkWell pilot sites will receive a share of the £1.5m fund, amounting to £100,000 per site, to support up to 56,000 individuals by early 2026. "UK launches fund to support people with health conditions return to work" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
